- Home
- Companies
- united kingdom
- pancreas
Refine by
Industries served
- Medical / Health Care
- Defense
- Aerospace & Air Transport
- Paint
- Plastics & Resins
- Chemical & Pharmaceuticals
- Waste and Recycling
- Oil, Gas & Refineries
- Water and Wastewater
- Agriculture
- Monitoring and Testing
- Environmental
- Health and Safety
- Air and Climate
- Soil and Groundwater
- University / Academia / Research
- Government
- Manufacturing, Other
- Publishing / Media / Marketing
- Food and Beverage
- Energy
Pancreas Suppliers In United Kingdom
7 companies found
based inCrumlin, UNITED KINGDOM
A global market leader within the in vitro diagnostics industry, Randox Laboratories develops innovative diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. ...
The Randox range of clinical chemistry reagents is extensive with a wide range of assays to suit your needs. Investing heavily in research and development, we continuously expand our portfolio to ensure increased choice of high quality reagents. ...
based inBellefonte, PENNSYLVANIA (USA)
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 19,000 employees and 65 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific ...
based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
The Modi-2 vaccine exploits a second post-translational modification, stimulating the production of CD4 T cells using tumour-associated peptide epitopes in which the lysine residues are converted to homocitrulline. This change occurs via a process ...
based inLund, SWEDEN
Camurus is committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic conditions, including opioid dependence, pain, cancer and endocrine disorders. New drug products are based on our ...
based inLondon, UNITED KINGDOM
We’ve been independent since day one and our independence is guaranteed indefinitely. This means that for six decades we have measured success not by share price but by how we ‘build bridges to knowledge’ - helping develop ideas through the research ...
DST covers all aspects of diabetes technology including glucose monitoring; insulin and metabolic peptide delivery; the artificial and bioartificial pancreas, telemedicine; software for modeling; physiologic monitoring; technology ...
based inOxford, UNITED KINGDOM
Perspectum delivers cutting-edge digital technologies that help clinicians provide better care for patients with liver disease, diabetes, and cancer. With a strong focus on precision medicine using advanced imaging and genetics, our vision is to ...
This ground-breaking new quantitative imaging tool uses computational techniques to enhance MRCP images. MRCP+ combines true 3D rendering of the enhanced data with quantitative characterization, facilitating clear mapping of the biliary tree and ...
based inOxford, UNITED KINGDOM
Founded in 2012, we are the leading pharmatech company and the first to automate drug discovery. As a full stack AI drug discovery company, we generate our own data before combining the analytical power of AI with the creativity and expertise of our ...
EXS21546 is our peripherally-restricted and selective antagonist of the Adenosine A2a Receptor. It is designed for anti-cancer immunotherapy, combatting adenosine related immunosuppressive effects, through T-cell ...